tradingkey.logo
tradingkey.logo
Search

Vistagen Therapeutics Inc

VTGN
Add to Watchlist
0.241USD
0.0000.00%
Close 07-31 16:00ETQuotes delayed by 15 min
9.55MMarket Cap
LossP/E TTM

VTGN Financials

See Vistagen Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Vistagen Therapeutics Inc Earnings Date

Latest Release
Jun 15, 2026
EPS / Forecast
-1.83/--
Revenue / Forecast
1.27M/--
Period
FY2026 Earnings
Revenue(YoY)
1.27M
161.11%
EPS(YoY)
-1.83
-9.91%
Analyst Rating
HOLD
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Financial Indicators
EPS
11.01%-0.38
2.46%-0.45
-28.37%-0.54
-34.80%-0.47
-38.48%-0.43
-112.32%-0.46
35.50%-0.42
62.52%-0.35
99.41%-0.31
84.74%-0.22
---0.66
---0.94
---52.71
---1.42
---5.41
----
----
----
----
----
Revenue
--465.00K
29.49%303.00K
40.98%258.00K
190.48%244.00K
----
-43.12%234.00K
-34.10%183.00K
-52.70%84.00K
12.36%197.30K
129.06%411.40K
131.11%277.70K
-42.73%177.60K
351.41%175.60K
-49.82%179.60K
-349.30%-892.50K
-12.43%310.10K
-91.20%38.90K
14.13%357.90K
7.19%358.00K
--354.10K
Net Profit
-19.35%-16.27M
-34.14%-18.90M
-49.81%-19.42M
-40.64%-15.10M
-43.20%-13.63M
-121.88%-14.09M
-96.75%-12.96M
-55.48%-10.73M
22.13%-9.52M
34.95%-6.35M
62.32%-6.59M
65.09%-6.90M
26.73%-12.23M
9.14%-9.76M
-32.75%-17.48M
-143.96%-19.78M
43.54%-16.69M
-90.07%-10.74M
-261.31%-13.17M
-134.11%-8.11M
Net Margin
---3499.78%
-3.59%-6237.29%
-6.26%-7525.97%
51.58%-6186.48%
----
-290.09%-6020.94%
-198.56%-7082.51%
-228.73%-12777.38%
30.69%-4825.85%
71.60%-1543.46%
---2372.24%
---3886.88%
---6962.98%
---5434.97%
----
----
----
----
----
----
Gross Margin
--100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
Debt to assets ratio
--0.20%
--0.58%
--0.81%
--1.35%
----
----
----
----
-100.00%0.00%
-99.58%0.01%
--0.02%
--5.27%
--0.54%
--1.44%
--1.82%
----
----
----
----
----
Revenue
--465.00K
29.49%303.00K
40.98%258.00K
190.48%244.00K
----
-43.12%234.00K
-34.10%183.00K
-52.70%84.00K
12.36%197.30K
129.06%411.40K
131.11%277.70K
-42.73%177.60K
351.41%175.60K
-49.82%179.60K
-349.30%-892.50K
-12.43%310.10K
-91.20%38.90K
14.13%357.90K
7.19%358.00K
--354.10K
Operating profit
-15.33%-16.72M
-29.27%-19.55M
-40.95%-20.05M
-30.28%-15.80M
-27.61%-14.49M
-91.78%-15.12M
-109.83%-14.23M
-73.35%-12.13M
7.19%-11.36M
19.28%-7.88M
61.23%-6.78M
64.61%-7.00M
26.68%-12.24M
7.34%-9.77M
-36.64%-17.49M
-155.26%-19.77M
-168.42%-16.69M
-98.90%-10.54M
-288.61%-12.80M
-148.13%-7.75M
Net Profit
-19.35%-16.27M
-34.14%-18.90M
-49.81%-19.42M
-40.64%-15.10M
-43.20%-13.63M
-121.88%-14.09M
-96.75%-12.96M
-55.48%-10.73M
22.13%-9.52M
34.95%-6.35M
62.32%-6.59M
65.09%-6.90M
26.73%-12.23M
9.14%-9.76M
-32.75%-17.48M
-143.96%-19.78M
43.54%-16.69M
-90.07%-10.74M
-261.31%-13.17M
-134.11%-8.11M
Current assets
-42.81%46.94M
-29.68%63.24M
-21.02%78.93M
-39.81%66.72M
-31.98%82.08M
-29.80%89.94M
155.78%99.95M
857.25%110.84M
589.26%120.67M
391.66%128.11M
5.86%39.08M
-78.95%11.58M
-75.34%17.51M
-69.97%26.06M
-61.72%36.91M
-44.91%54.99M
-31.81%71.00M
-17.36%86.77M
503.79%96.44M
4481.48%99.83M
Total current liabilities
1.45%12.79M
40.62%13.53M
81.36%13.64M
78.88%11.15M
146.18%12.61M
131.02%9.62M
158.57%7.52M
54.01%6.24M
12.16%5.12M
-2.87%4.16M
-51.87%2.91M
-54.64%4.05M
-20.78%4.57M
-33.23%4.29M
-23.59%6.05M
42.43%8.93M
37.62%5.77M
115.38%6.42M
139.63%7.91M
134.45%6.27M
Total assets
-42.42%48.56M
-29.52%65.06M
-21.04%80.93M
-39.30%68.92M
-31.79%84.34M
-29.57%92.31M
142.91%102.50M
655.36%113.55M
486.33%123.65M
341.18%131.07M
3.67%42.20M
-74.40%15.03M
-71.75%21.09M
-67.19%29.71M
-59.50%40.70M
-43.48%58.73M
-31.07%74.64M
-17.15%90.54M
395.79%100.50M
1584.92%103.91M
Total liabilities
-6.50%13.04M
26.38%14.14M
53.22%14.59M
39.04%12.16M
48.94%13.95M
43.71%11.19M
45.36%9.52M
6.86%8.74M
3.97%9.37M
-13.85%7.78M
-40.97%6.55M
-35.43%8.18M
-9.26%9.01M
-14.43%9.03M
-44.07%11.10M
-30.71%12.67M
-39.10%9.93M
-31.71%10.56M
23.63%19.84M
55.29%18.29M
Total equity
-49.54%35.52M
-37.23%50.92M
-28.65%66.34M
-45.84%56.77M
-38.41%70.39M
-34.20%81.12M
160.83%92.97M
1430.19%104.80M
846.08%114.29M
496.31%123.28M
20.40%35.65M
-85.13%6.85M
-81.33%12.08M
-74.15%20.67M
-63.30%29.61M
-46.21%46.05M
-29.64%64.72M
-14.75%79.98M
1810.19%80.66M
1625.68%85.62M
Net operating income
-61.00%-16.20M
-71.51%-17.63M
-26.39%-13.76M
-73.39%-18.85M
-39.81%-10.06M
-126.66%-10.28M
-75.88%-10.89M
-37.74%-10.87M
3.69%-7.20M
54.34%-4.54M
62.12%-6.19M
50.58%-7.89M
52.06%-7.47M
17.54%-9.93M
-42.72%-16.34M
-158.68%-15.97M
-195.13%-15.59M
-141.46%-12.05M
-1240.74%-11.45M
-119.93%-6.17M
Net investment
-118.79%-99.00K
124.64%104.00K
98.79%-94.00K
85.59%-788.00K
1936.24%527.00K
-1206.50%-422.00K
---7.79M
---5.47M
94.57%-28.70K
-158.40%-32.30K
100.00%0.00
100.00%0.00
-528200.00%-528.30K
-12600.00%-12.50K
51.68%-24.40K
-16.81%-175.10K
99.61%-100.00
100.07%100.00
48.89%-50.50K
---149.90K
Net financing
-114.51%-283.00K
80.36%2.11M
--27.65M
1590.91%1.49M
1262.69%1.95M
-98.75%1.17M
-100.00%0.00
-89.95%88.00K
57.91%-167.80K
30852.55%93.52M
10332.25%34.18M
16020.00%875.60K
-1782.28%-398.70K
-114.35%-304.10K
-104.54%-334.00K
-100.55%-5.50K
-99.42%23.70K
-97.75%2.12M
-43.24%7.35M
-66.93%991.40K

FAQs

What is the total revenue of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2026 earnings report, its total revenue reached 1.27M, with a year-on-year change of 486.00K.

What are the current assets of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2026 earnings report, its current assets were 46.94M, with a year-on-year change of -42.81.

What are the total assets of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2026 earnings report, its total assets of Vistagen Therapeutics Inc were 48.56M, with a year-on-year change of -42.42.

What are the total liabilities of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2026 earnings report, its total liabilities of Vistagen Therapeutics Inc were 13.04M, with a year-on-year change of -6.50.

What is the total equity of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2026 earnings report, its total equity of Vistagen Therapeutics Inc was 35.52M, with a year-on-year change of -49.54.

What is the net operating income of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2026 earnings report, its net operating income of Vistagen Therapeutics Inc was -72.13M, with a year-on-year change of -28.86.

What is the net investment of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2026 earnings report, its net investment of Vistagen Therapeutics Inc was -877.00K, with a year-on-year change of 93.33.

What is the net financing of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2026 earnings report, its net financing of Vistagen Therapeutics Inc was 30.97M, with a year-on-year change of 864.83.

What is the Earnings Per Share (EPS) of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2026 earnings report, its Earnings Per Share (EPS) was -1.83, with a year-on-year change of -9.91.

What is the net income of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2026 earnings report, its net income was -69.69M, with a year-on-year change of -35.53.

What is the net margin of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2026 earnings report, its net profit margin was -5491.33, with a year-on-year change of 48.10.

What is the Return on Equity (ROE) of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2026 earnings report, its Return on Equity (ROE) was -131.59, with a year-on-year change of -136.32.

What is the Return on Assets (ROA) of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2026 earnings report, its Return on Assets (ROA) was -104.86, with a year-on-year change of -112.10.

What is the operating profit of Vistagen Therapeutics Inc?

According to Vistagen Therapeutics Inc's FY2026 earnings report, its operating profit was -72.13M, with a year-on-year change of -28.86.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.